Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) vs Romania: Access to anti-retroviral drugs, male
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
22.9%
in 2024
Romania
89.0%
in 2024
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank
18th
Romania rank
17th
Access to anti-retroviral drugs, male over time
- Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
- Romania
How they compare
Romania currently reports 89.0% against 22.9% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), a difference of 66.1%.
That makes Romania's figure about 3.9 times Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)'s.
Across all 25 years both countries report, Romania has been ahead every year.
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 18th and Romania ranks 17th of 19 groups.
Romania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) | Romania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.3% | 39.9% | 36.6% | Romania |
| 2010s | 10.3% | 59.8% | 49.5% | Romania |
| 2020s | 19.4% | 79.2% | 59.8% | Romania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) or Romania?
- Romania, at 89.0% against 22.9% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Romania?
- 66.1%, with Romania ahead.
- How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Romania?
- 25 years are reported by both, from 2000 to 2024.
- How do Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Romania rank globally for access to anti-retroviral drugs, male?
- Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 18th and Romania ranks 17th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.